June 29, 2020 / 1:13 PM / 17 days ago

BRIEF-TFF Pharmaceuticals Reports Topline Data For Voriconazole Inhalation Powder

June 29 (Reuters) - TFF Pharmaceuticals Inc:

* TFF PHARMACEUTICALS ANNOUNCES FIRST HUMAN DOSING WITH TACROLIMUS INHALATION POWDER AND TOPLINE DATA FOR VORICONAZOLE INHALATION POWDER

* TFF PHARMACEUTICALS - VORICONAZOLE DOSES OF UP TO 80 MG/DOSE IN HEALTHY NORMAL VOLUNTEERS WERE SHOWN TO BE SAFE AND WELL TOLERATED Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below